Khaleej Times on MSN
'We can end HIV': Groundbreaking preventative drug to be rolled out for $40 a year from 2027
Global health agencies announced Wednesday that generic versions of a groundbreaking injectable drug to prevent HIV will be ...
A groundbreaking injectable drug, lenacapavir, offers renewed hope in the fight against HIV. Set to be available in 2027 in ...
Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 ...
Newborns exposed to HIV during pregnancy or birth should receive preventive antiretroviral medication immediately after ...
Lenacapavir is a long-acting injectable antiretroviral drug developed by Gilead Sciences. It is administered just twice a year and has demonstrated over 99.9% effectiveness in preventing HIV ...
Globally, 630,000 people died from HIV-related causes in 2024, while 1.3 million people acquired HIV, including 120,000 ...
A total of 636 new cases of Human Immunodeficiency Virus (HIV) infections have been recorded in the Ahafo Region in the first ...
The global HIV diagnostics market is expected to grow at a CAGR of ~10% during the forecast period. Rising prevalence of HIV ...
This antiretroviral has shown unprecedented results in HIV prevention, requiring only two injections per year. Its ...
Discover how lenacapavir, a revolutionary HIV prevention tool, will be available for just $40 annually to 120 low- and middle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback